Findings from the health outcomes group at Fred Hutchinson Cancer Research Center show that more Medicaid patients with cancer died at home without hospice care during the COVID-19 pandemic.
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
